Development and characterization of a mouse in vitro model of ischaemia-induced ventricular fibrillation

Cardiovasc Res. 2009 Jul 15;83(2):397-404. doi: 10.1093/cvr/cvp068. Epub 2009 Feb 19.

Abstract

Aims: We sought to generate a mouse Langendorff model of ischaemia-induced ventricular fibrillation (VF) that does not depend on triggers such as programmed electrical stimulation.

Methods and results: Hearts from male Tuck Ordinary mice were perfused with Krebs solution (modified to contain low-normal K(+), 3 mmol/L, and high Ca(2+), 2.4 mmol/L) containing different combinations of catecholamines (epinephrine 313 nmol/L plus norepinephrine 75 nmol/L) and/or angiotensin II (100 pmol/L) designed to mimic the in vivo milieu. VF was absent during 30 min regional ischaemia (and during 10 min reperfusion) in Krebs-perfused hearts. Catecholamines unmasked ischaemia-induced VF (50%; P < 0.05) and reperfusion-induced VF (50%; P < 0.05). Co-perfusion with angiotensin II did not facilitate VF. Supraventricular pacing (600 b.p.m.) stabilized pre-ischaemic sinus rhythm and partially mimicked the VF-unmasking effect of catecholamines. Arrhythmia susceptibility was greatest with supraventricular pacing plus catecholamines (57% VF during ischaemia and 71% during reperfusion).

Conclusion: For the first time, regional ischaemia-induced VF was consistently evoked in a mouse Langendorff preparation, unmasked by simple periphysiological manipulation of the perfusion conditions. The model is suitable for functional genomic studies.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensin II / administration & dosage
  • Animals
  • Cardiac Pacing, Artificial / adverse effects
  • Catecholamines / administration & dosage
  • Disease Models, Animal*
  • Electrocardiography
  • Heart Rate*
  • Male
  • Mice
  • Myocardial Ischemia / complications*
  • Myocardial Ischemia / physiopathology
  • Myocardial Reperfusion / adverse effects*
  • Myocardial Reperfusion Injury / etiology*
  • Myocardial Reperfusion Injury / physiopathology
  • Perfusion
  • Time Factors
  • Ventricular Fibrillation / etiology*
  • Ventricular Fibrillation / physiopathology

Substances

  • Catecholamines
  • Angiotensin II